These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23528905)

  • 1. Ptosis: a rare presentation of Hodgkin lymphoma.
    Gupta V; Kumar M; Gupta SK
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):163-5. PubMed ID: 23528905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relapse of Hodgkin disease after 17 years of complete remission. A case report].
    Osorio G; Caglevic C
    Rev Med Chil; 2003 Feb; 131(2):197-9. PubMed ID: 12708259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin lymphoma with cutaneous involvement.
    Hsia CC; Howson-Jan K; Rizkalla KS
    Dermatol Online J; 2009 May; 15(5):5. PubMed ID: 19624983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune thrombocytopenic purpura preceding Hodgkin lymphoma].
    Goshen Y; Kalinsky H; Umiel T; Pecht M; Zaizov R
    Harefuah; 1987 Nov; 113(9):209-12. PubMed ID: 2448195
    [No Abstract]   [Full Text] [Related]  

  • 5. Hodgkin lymphoma in a child with Diamond Blackfan anemia.
    Yaris N; Erduran E; Cobanoglu U
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):234-6. PubMed ID: 16679921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
    Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome.
    Jovanovic A; Minic P; Scekic-Guc M; Djuricic S; Cirkovic S; Weemaes C; Pasic S
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):49-52. PubMed ID: 19125088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy.
    Katsumata R; Sagawa R; Akechi T; Shinagawa Y; Nakaaki S; Inagaki A; Okuyama T; Akazawa T; Furukawa TA
    Jpn J Clin Oncol; 2010 Apr; 40(4):365-8. PubMed ID: 20026458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of malignant lymphomas].
    Luporini G
    Radiol Med; 1976; 62(7-8):553-7. PubMed ID: 95671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 12. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis.
    Martinelli G; Cocorocchio E; Peccatori F; Zucca E; Saletti PC; Calabrese L; Pastano R; Pruneri G; Mazzetta C; Ghielmini M; Cavalli F
    Br J Haematol; 2004 Jun; 125(5):584-9. PubMed ID: 15147373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
    Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
    Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of splenomegaly in childhood Hodgkin disease.
    Arya LS; Dinand V; Bakhshi S; Thavaraj V; Singh R; Dawar R
    J Pediatr Hematol Oncol; 2004 Dec; 26(12):807-12. PubMed ID: 15591900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hodgkin disease and amyloidosis].
    Jekunen A; Maiche A; Laurila P; Franssila K; Elomaa I
    Duodecim; 1994; 110(6):602-6. PubMed ID: 7555860
    [No Abstract]   [Full Text] [Related]  

  • 17. Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report.
    Basić-Jukić N; Radman I; Roncević T; Jakić-Razumović J
    Croat Med J; 2002 Oct; 43(5):573-5. PubMed ID: 12402399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 20. Hodgkin's lymphoma--the great teacher.
    Connors JM
    N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.